1,092
Views
19
CrossRef citations to date
0
Altmetric
Methodology

Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning

, , , , , , , , , , , , , , , , , , , , , , & show all
Pages 557-564 | Received 20 Jan 2015, Accepted 11 May 2015, Published online: 10 Jun 2015

References

  • Sites BD, Taenzer AH, Herrick MD, Gilloon C, Antonakakis J, Richins J, Beach ML. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med 2012; 37:478–482.
  • Mowry JB, Spyker DA, Cantilena LR, Jr., Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report. Clin Toxicol 2013; 51:949–1229.
  • Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 1998; 88:1071–1075.
  • Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105:217–218.
  • Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, et al.Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008; 51:412–415, 415 e1.
  • American College of Medical Toxicology. ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol 2011; 7:81–82.
  • Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: A systematic review of human and animal studies. Clin Toxicol 2010; 48:1–27.
  • Cave G, Harvey M, Graudins A. Review article: Intravenous lipid emulsion as antidote: A summary of published human experience. Emerg Med Australas 2011; 23:123–141.
  • Waring WS. Intravenous lipid therapy: A systematic review of published case reports. Clin Toxicol 2012; 50:365–366.
  • Butterworth JF 4th. Models and mechanisms of local anesthetic cardiac toxicity: a review. Reg Anesth Pain Med 2010; 35:167–176.
  • Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336:995–998.
  • Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et alAGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182:E839–E842.
  • Institute Of Medicine. Clinical Practice Guidelines We Can Trust. Washington DC: National Academies Press, 2011.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
  • Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c332.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61:344–349.
  • Gagnier JJ, Riley D, Altman DG, Moher D, Sox H, Kienle G, CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. Dtsch Arztebl Int 2013; 110:603–608.
  • Lavergne V, Ouellet G, Bouchard J, Galvao T, Kielstein JT, Roberts DM, et al.Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial 2014; 27:407–414.
  • Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8:e1000412.
  • Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernandez AM, et al.Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007; 30:367–373.
  • Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, et al.Incorporating considerations of resources use into grading recommendations. BMJ 2008; 336:1170–1173.
  • Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al.The RAND/UCLA appropriateness method user's manual. Santa Monica, CA2011. Available from: http://www.rand.org. (Last Accessed on 15 December 2014).
  • Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization. Ann Intern Med 2003; 139:493–498.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.